Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Effects of Rosuvastatin vs Simvastatin in Dyslipidaemia
NCT00654446Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2002
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of rosuvastatin in dyslipidemia, sponsored by AstraZeneca. Started Sep 2002; status: completed.
02
Drugs
rosuvastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00654446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654446.